Growing regenerative drug pipeline offers opportunities in bone and joint applications

company logo

Global Regenerative Medicines Market:

Global Regenerative Medicines Market:

Global Regenerative Medicines Market:

Dublin, June 24, 2022 (GLOBE NEWSWIRE) — The report “Regenerative Medicines: Bone and Joint Applications” has been added to’s offer.


  • Anika Therapeutics Inc.

  • Arthrex Inc.

  • Baxter International Inc.

  • Bioventus

  • Conmed Corp.

  • Depuy Synthes Products Inc. (part of Johnson & Johnson)

  • Medtronic plc

  • Seikagaku Corp.

  • Smith & Nephew plc

  • Stryker Corp.

  • Zimmer Biomet Holdings Inc.

Report contains

  • An overview of the global market for regenerative drugs for bone and joint applications

  • Market size estimation and analyzes of global market trends, with data from 2020 to 2021, estimates for 2022, with compound annual growth rates (CAGRs) forecasts to 2027

  • Characterization and quantification of market potential for regenerative drugs by technology, application and region

  • Coverage and discussion of regulatory delays due to COVID-19, industry clinical trials and product launches

  • Description of principled approaches to regenerative medicine and discussion on the importance of scaffolding in tissue engineering

  • Information on key drivers and regional market dynamics and current industry trends

  • Market share analysis of the industry’s key companies and reporting of events such as mergers and acquisitions, joint ventures, collaborations or partnerships and other key market strategies

Reasons to do this study:

The purpose of this report is to provide an overview of regenerative medicine products for the treatment of diseases and disorders of bones and joints. Regenerative therapies have the potential to improve medical outcomes, improve quality of life and reduce overall health care costs.

An important goal is to use living cells to repair or replace body tissue that has been damaged by injury, disorder or the aging process. The most successful products are based on multidisciplinary fields such as biology, medicine, engineering and, in particular, biomedical technology.

This report is designed as a critical decision-making tool for the targeted audience, including biopharmaceutical market players, potential market entrants, and other professionals involved or interested in cell and gene therapy and regenerative therapy in the orthopedic industry.

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and technology background

  • Overview of regenerative medicine

  • How regenerative medicine works

  • Main approaches to regenerative medicine

  • Cells and Tissues

  • tissue technique

  • Importance of scaffolding in tissue engineering

  • Plastic scaffolding

  • Blood vessel scaffold

  • Center for Integration of Medicine and Innovative Technology (CIMIT)

  • Embryonic Stem Cells

Chapter 4 Impact of Covid-19

  • Overview

  • Impact of Covid-19 on cell and gene therapies and regenerative medicine for bone and joint applications

  • Direct impact on clinical trials in cell and gene therapy

Chapter 5 Market Dynamics

  • Market factors

    • Rising number of bone and joint disorders and orthopedic surgeries

    • Increasing product approvals and launches

    • R&D for strain and gene therapies

  • Market Restrictions

  • Market opportunities

  • Competitive landscape

Chapter 6 Market breakdown by technology

Chapter 7 Market Breakdown by Application

Chapter 8 Market Breakdown by Region

For more information on this report, please visit


CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Leave a Comment